NPCE
NPCE
NASDAQ · Health Care

Neuropace Inc

$15.67
+0.18 (+1.16%)
As of Feb 8, 1:50 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +171.0% upside
Low Target $26.30
Average Target $42.46
High Target $52.67
Current Price $15.67
Current
$15.67
Target
$42.46
$26.30 $42.46 avg $52.67
Scenario Analysis
Bear Case
$26.30
67.8%
Low target
Base Case
$42.46
+171.0%
Avg target
Bull Case
$52.67
+236.1%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$18.98
-17.4% from high
52-Week Low
$7.56
+107.2% from low
Target vs 52W High
$42.46
+123.8% vs high
Next Earnings Report
Mar 2, 2026 · After Market Close
13d
until earnings
EPS Est: $-0.15
Earnings in 13 days. Analyst targets may shift significantly after the report.
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +6.2%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +9.6%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -54.8%
SYK
Stryker Corp
Strong Buy 36 75% $338.36 -5.6%
MDT
Medtronic Plc
Buy 35 57% $192.46 +87.0%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -67.1%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -78.0%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +82.4%